Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

Edelweiss Mutual Fund

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

★★★★★ TopFund est.

TopFund Score (fallback rating)

  • Calculated by: TopFund — used only when no third-party rating exists for this fund
  • Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis

Full rating methodology →

TopFund Score: 87/100 · Excellent

How this score is calculated

  • Star rating (35%)4/5
  • 3Y CAGR (30%)18.85%
  • Expense ratio (20%)0.59%
  • AUM (15%)₹1,541 Cr

Not investment advice — an analytical read of public fund data. Methodology →

Edelweiss Mutual Fund · Other · Index Funds

₹23.86

+0.08 (+0.33%)

AUM: ₹1,541 Cr

NAV updated 28 days ago

Plan

Direct

Option

Growth

Risk

High

Expense Ratio

0.59%

Exit Load

Exit load of 0.50%, if redeemed within 3 months.

Fund Manager

Aditya Khemani

Inception

Sep 2026

Benchmark

BSE Healthcare Total Return Index

Sharpe Ratio

0.56

Std Dev (1Y)

11.64%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

-4.71%

3m

-1.87%

6m

+12.92%

1y

+13.23%

3y

+18.85%

5y

+13.59%

10y

+15.12%

since inception

+15.7%

TopFund's Take on Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth ranks among the stronger performers in the Index Funds category, backed by a 4-star rating. Consistent 3-year performance combined with a strong rating makes this one of the more credible options in its space. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 87/100.

Cost: At 0.59%, the expense ratio runs 40% above the Index Funds category average of 0.42%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a moderate Sharpe ratio of 0.6 — decent risk-adjusted performance, without being exceptional. Separately, annualised volatility of 11.62% is on the lower side for a Index Funds fund, suggesting a comparatively smoother ride.

Who should invest: This fund is best suited to cost-conscious investors happy to simply match the market rather than try to beat it. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Asset Allocation

Equity 97.42%
Cash/Net Current Assets 2.34%
Repo 0.24%

Frequently Asked Questions about Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.